Fundraising Fox

Endoshunt

Lincoln, US · Founded 2022 · 6 employees on LinkedIn · 3 known investors

EndoShunt develops a catheter-based device to control hemorrhage in traumatic vascular injuries, featuring a length-adjustable occlusion zone, temporary deployment, and an atraumatic tip. The company has functional prototypes validated in benchtop and in vivo studies and is pursuing FDA 510(k) clearance.

Founders & leadership

Endoshunt was founded in 2022 by Michael Finn-Henry.

MF
Michael Finn-HenryinPresident and Member of Board of Directors
JL
Jeremy LevinNamed on SEC filing

Board

MB
Milad BehbahaniniaMember of Board of Directors
OB
Olivia BuskMember of Board of Directors

Investors · 3

Reported raises · per SEC filings

Form D private placements

$75K disclosed across 1 round · 2022

$75KraisedNov 2022 · 2 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Jeremy LevinDirector
  • Milad BehbahaniniaDirector
  • Olivia BuskDirector
  • Michael Finn-HenryExecutive Officer, Director
Offering amount
$75K
Amount sold
$75K
First sale
Nov 2022
Incorporated
Corporation, Delaware, 2022
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

In the news

Frequently asked questions

What does Endoshunt do?
EndoShunt develops a catheter-based device to control hemorrhage in traumatic vascular injuries, featuring a length-adjustable occlusion zone, temporary deployment, and an atraumatic tip. The company has functional prototypes validated in benchtop and in vivo studies and is pursuing FDA 510(k) clearance.
Who founded Endoshunt?
Endoshunt was founded by Michael Finn-Henry in 2022.
Who are Endoshunt's investors?
Endoshunt's investors include New York Angels, Octerra Capital, The Innovation Space.
How much funding has Endoshunt raised?
Endoshunt has disclosed $75K raised across 1 round.
Where is Endoshunt headquartered?
Endoshunt is headquartered in Lincoln, US.